Sucampo Pharma (SCMP) Misses Q3 EPS by 2c

November 4, 2015 6:35 AM EST

Sucampo Pharma (NASDAQ: SCMP) reported Q3 EPS of $0.16, $0.02 worse than the analyst estimate of $0.18. Revenue for the quarter came in at $33.5 million versus the consensus estimate of $36.18 million.

For earnings history and earnings-related data on Sucampo Pharma (SCMP) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings